In models of depression, the antidepressant effects of certain drugs, especially rapid-acting drugs such as ketamine, are significantly reduced when an mTOR inhibitor (e.g., rapamycin) is administered [190, 191]. The gene discussed is MTOR; the disease is depressive symptom measurement.